CyberMed

Coordinated Vulnerability Disclosure

Post-Market Security Management · 2 min read

Coordinated vulnerability disclosure (CVD) gives security researchers a sanctioned way to report flaws in your devices, and gives you time to develop a fix before the details go public. At minimum you need a published policy, a monitored reporting channel like security@yourcompany.com, and response timelines you actually keep.

5.6.1 Understanding CVD

Coordinated Vulnerability Disclosure (CVD) is the process of working with security researchers who find vulnerabilities. FDA references ISO 29147:2018 and ISO 30111:2013 as standards for CVD.

Why CVD Matters

Benefits:

  • Find vulnerabilities before attackers
  • Build researcher relationships
  • Demonstrate security maturity
  • Improve products

Without CVD:

  • Researchers go public immediately
  • No time to develop patches
  • Surprised by disclosures
  • Reputation damage

5.6.2 Setting Up Your CVD Program

Essential Elements

Clear Reporting Channel:

security@manufacturer.com
https://manufacturer.com/security
PGP key for encrypted reports

Published Policy:

  • Scope (what products)
  • Process (what happens)
  • Timeline (response times)
  • Recognition (acknowledgments)

Example CVD Policy Structure:

# Coordinated Vulnerability Disclosure Policy

## Scope
This policy applies to all [Manufacturer] medical devices 
and associated software.

## Reporting
Email: security@manufacturer.com
PGP: [Key fingerprint]
Web: https://manufacturer.com/report-vulnerability

## Our Commitment
- Acknowledge receipt within 5 business days
- Provide severity assessment within 10 days
- Regular updates on progress
- Coordinate disclosure timing

## Recognition
- Public acknowledgment (with permission)
- Inclusion in security advisories
- Good faith commitment

## Out of Scope
- Physical attacks requiring device modification
- Social engineering of our staff
- Denial of service attacks

5.6.3 Managing Researcher Relationships

Initial Response Template:

Subject: Re: Vulnerability Report - [Device Name]

Thank you for your vulnerability report dated [date].

We confirm receipt and are beginning our assessment.

Tracking number: VULN-2024-001
Expected initial assessment: [date + 10 days]

We'll provide regular updates on our progress.

Best regards,
[Product Security Team]

Relationship Best Practices:

  • Respond promptly
  • Be professional
  • Show appreciation
  • Keep promises
  • Give credit

5.6.4 Disclosure Timeline Negotiation

Work with researchers on disclosure timing:

Standard Timeline:

  • 0 days: Report received
  • 5 days: Acknowledgment
  • 10 days: Initial assessment
  • 30-120 days: Patch development
  • X days: Coordinated disclosure

Factors Affecting Timeline:

  • Vulnerability severity
  • Exploit complexity
  • Patch difficulty
  • Deployment challenges
  • Patient risk

Sources

Primary documents named in this section:

  1. ISO/IEC 29147:2018, Information technology: Security techniques, Vulnerability disclosure, ISO/IEC.

See how your device measures up

Take the free FDA 524B readiness assessment and get a personalized gap report covering this topic and more.

Check Your Readiness

Need the documents written, not just checked? CyberMed writes the eSTAR cybersecurity section and runs the penetration testing behind it.